Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Letters to the Editor

CHALLENGE Trial 1 Year Feasibility Results—Letter

Claire H. Pernar, Sarah C. Markt, Rana R. McKay and Lorelei A. Mucci
Claire H. Pernar
1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cpernar@mail.harvard.edu
Sarah C. Markt
1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rana R. McKay
2Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorelei A. Mucci
1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-16-0393 Published August 2016
  • Article
  • Info & Metrics
  • PDF
Loading

We were delighted to read the recent report by Courneya and colleagues on the 1-year feasibility and fitness benefits of a structured exercise program among colon cancer survivors in the CHALLENGE Trial (1). These findings, and the expected 3-year follow-up data, are an important contribution to the nascent body of research examining the effectiveness of sustained exercise behavior change in cancer patients.

The potential survival benefits of exercise to cancer patients have been well documented across multiple sites among men and women in epidemiologic studies (2, 3). With 32 million people living with cancer worldwide, the potential benefit of effective interventions could be enormous (4). However, lifestyle intervention studies pose unique challenges and must achieve balance between complexity to produce optimal behavior change and practicality for scalability. Courneya and colleagues confront these challenges through ongoing sessions of exercise paired with behavior support over three years and multicenter implementation.

We identify key areas warranting further investigation. First, complex exercise regimens may not be necessary to obtain health benefits in cancer patients. Notably, observational studies have shown activities such as brisk walking can produce gains in both survival and quality of life. Although patients broadly may benefit from exercise, there is unlikely to be a single regimen that is optimal for all individuals. Researchers might improve adherence and sustainability by targeting interventions to meet the needs and limitations of specific patient populations, for instance, by considering age, disease stage, and treatment type. Furthermore, there is growing evidence that tumor heterogeneity contributes to intervention efficacy differences. For example, the effect of exercise on colorectal cancer survival differed for patients by insulin receptor substrate 1 (IRS1) status (5). Through multidisciplinary collaboration, future research may enhance our understanding of interactions between tumor characteristics and physical activity so that interventions can be targeted to provide the greatest benefit. Finally, further investigation is needed to examine the long-term effects of physical activity. Interventions of longer duration, as exemplified by the CHALLENGE Trial, may be required to achieve maximal improvements in quality of life and survival. Furthermore, integrating web-based technologies may enhance adherence over the long term while reducing costs of in-person interactions. There is an urgent need to further develop the evidence base for exercise interventions in cancer patients to maintain positive behavior change over the lifetime and maximize overall health benefit.

We commend the approach taken by Courneya and colleagues and look forward to the 3-year results from CHALLENGE.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Grant Support

C.H. Pernar is supported by NIH training grant T32 ES 007069. S.C. Markt is supported by NIH training grant T32 CA 09001. L.A. Mucci and R.R. McKay are Prostate Cancer Foundation (PCF) Young Investigators. R.R. McKay receives research funding from Bayer and Pfizer.

  • Received May 10, 2016.
  • Accepted May 11, 2016.
  • ©2016 American Association for Cancer Research.

References

  1. 1.↵
    1. Courneya KS,
    2. Vardy JL,
    3. O'Callaghan CJ,
    4. Friedenreich CM,
    5. Campbell KL,
    6. Prapavessis H,
    7. et al.
    Effects of a structured exercise program on physical activity and fitness in colon cancer survivors: one year feasibility results from the CHALLENGE Trial. Cancer Epidemiol Biomarkers Prev 2016;25:969–77.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Lee IM,
    2. Wolin KY,
    3. Freeman SE,
    4. Sattlemair J,
    5. Sesso HD
    . Physical activity and survival after cancer diagnosis in men. J Phys Act Health 2014;11:85–90.
    OpenUrlPubMed
  3. 3.↵
    1. Holmes MD,
    2. Chen WY,
    3. Feskanich D,
    4. Kroenke CH,
    5. Colditz GA
    . Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479–86.
    OpenUrlCrossRefPubMed
  4. 4.↵
    International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. Lyon, France: International Agency for Research on Cancer; [cited 2 May 2016]. Available from: http://globocan.iarc.fr.
  5. 5.↵
    1. Hanyuda A,
    2. Kim SA,
    3. Martinez-Fernandez A,
    4. Qian ZR,
    5. Yamauchi M,
    6. Nishihara R,
    7. et al.
    Survival benefit of exercise differs by tumor IRS1 expression status in colorectal cancer. Ann Surg Oncol 2016;23:908–17.
    OpenUrlPubMed
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 25 (8)
August 2016
Volume 25, Issue 8
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CHALLENGE Trial 1 Year Feasibility Results—Letter
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CHALLENGE Trial 1 Year Feasibility Results—Letter
Claire H. Pernar, Sarah C. Markt, Rana R. McKay and Lorelei A. Mucci
Cancer Epidemiol Biomarkers Prev August 1 2016 (25) (8) 1277; DOI: 10.1158/1055-9965.EPI-16-0393

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
CHALLENGE Trial 1 Year Feasibility Results—Letter
Claire H. Pernar, Sarah C. Markt, Rana R. McKay and Lorelei A. Mucci
Cancer Epidemiol Biomarkers Prev August 1 2016 (25) (8) 1277; DOI: 10.1158/1055-9965.EPI-16-0393
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Copy Number Variation and Ovarian Cancer Risk—Letter
  • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk—Response
  • Shift Work, Chronotype, and Cancer Risk—Response
Show more Letters to the Editor
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement